Histidine for Treatment of Uraemic Anaemia

Giordano, C.; De Santo, N. G.; Rinaldi, S.; Acone, D.; Esposito, R.; Gallo, B.
December 1973
British Medical Journal;12/22/1973, Vol. 4 Issue 5894, p714
Academic Journal
No abstract available.


Related Articles

  • High circulating concentrations of glucagon in non-anaemic uraemic patients. McEvoy, Joseph; McCarroll, Anne Mary // British Medical Journal;7/1/1978, Vol. 2 Issue 6129, p17 

    Examines concentration of glucagon in non-anaemic uraemic patients. Causes of anaemia of renal failure patients; Possibility of maintaining normal haemoglobin concentration and packed cell volumes; Similarity of renal failure anaemia and glucagonoma. .

  • Cellular basis of uraemic cardiomyopathy: a role for erythropoietin? Smith, Katie; Semple, David; Bhandari, Sunil; Seymour, Anne-Marie L. // European Journal of Heart Failure;Aug2009, Vol. 11 Issue 8, p732 

    The use of erythropoietin (EPO) has revolutionized the treatment of anaemia associated with many conditions including chronic kidney disease (CKD). However, little is known of the cellular impact of EPO on the uraemic heart. The discovery that the EPO receptor (EPOR) is also expressed on...

  • Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome. Durán, Carlos E.; Blasco, Miquel; Maduell, Francisco; Campistol, Josep M. // Clinical Kidney Journal;Jan2012, Vol. 5 Issue 1, p28 

    Haemolytic–uraemic syndrome is a clinical syndrome characterized by thrombocytopaenia, non-autoimmune haemolytic anaemia and renal impairment. Pathological alterations in kidney samples show thrombotic microangiopathy. The underlying pathogenesis is endothelial cell injury with thrombotic...

  • Haemolytic uraemic syndrome: therapeutic effect of plasma infusions. Misiani, Rocco; Appiani, Aldo Claris; Edefonti, Alberto; Gotti, Eliana; Bettinelli, Alberto; Giani, Marisa; Rossi, Edoardo; Remuzzi, Giuseppe; Mecca, Giuliano // British Medical Journal (Clinical Research Edition);11/6/1982, Vol. 285 Issue 6351, p1304 

    Evaluates on the therapeutic effect of plasma infusion in children and adults. Characterization of haemolytic uraemic syndrome; Presence of thrombocytopenia and microangiopathic haemolytic anaemia in patients; Administration of antihypertensive drugs on patients.

  • Prostacyclin deficiency in hemoglobin-uremic syndrome. Webster, J.; Rees, A.J.; Lewis, P.J.; Hensby, C.N. // British Medical Journal;7/26/1980, Vol. 281 Issue 6235, p271 

    The haemolytic-uraemic syndrome is characterised by microangiopathic haemolytic anaemia, renal failure, and platelet consumption. Prostacyclin (PGI[SUB2]) deficiency may be the primary defect in haemolytic uraemic syndrome and the related condition, thrombotic thrombo-cytopenoic purpura.[1] We...

  • Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency. Labrune, P.; Zittoun, J.; Duvaltier, I.; Trioche, P.; Marquet, J.; Niaudet, P.; Odièvre, M.; Odièvre, M // European Journal of Pediatrics;1999, Vol. 158 Issue 9, p734 

    An 18-month-old girl presented with macrocytic megaloblastic anaemia followed by haemolytic uraemic syndrome. Metabolic investigations led to the identification of an inborn error of cobalamin metabolism consisting of defective methylcobalamin biosynthesis, probably cobalamin G, since methionine...

  • Remission of aHUS neurological damage with eculizumab. Ávila, Ana; Vizcaíno, Belén; Molina, Pablo; Gavela, Eva; Perez-Ebri, Maria; Pallardó, Luís // Clinical Kidney Journal;Apr2015, Vol. 8 Issue 2, p232 

    Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by haemolytic microangiopathic anaemia, thrombocytopaenia and acute onset of renal failure, in the absence of Escherichia coli infection. Renal damage usually progresses to end-stage renal disease (ESRD), sometimes being...

  • erratum.  // Clinical Kidney Journal;Jun2012, Vol. 5 Issue 3, p284 

    A correction to the article "Treatment of Atypical Haemolytic Uraemic Syndrome in the Era of Eculizumab" that was published in a 2012 issue is presented.

  • Eculizumab.  // Reactions Weekly;2/4/2012, Issue 1387, p17 

    The article describes the case of a woman who developed vomiting and nausea following treatment with eculizumab for atypical haemolytic uraemic syndrome.

  • Sodium thiosulfate.  // Reactions Weekly;Mar2014, Vol. 1494 Issue 1, p40 

    An abstract of the article "Sodium thiosulphate treatment of uraemic tumoral calcinosis," by S. Malbos and colleagues is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics